Yoshiya Shimada Selected Research

Yoshiya Shimada Research Topics

Disease

42	Neoplasms (Cancer) 11/2022 - 10/2003
25	Carcinogenesis 11/2022 - 06/2004
15	Carcinoma (Carcinomatosis) 10/2022 - 04/2006
13	Breast Neoplasms (Breast Cancer) 10/2022 - 05/2006
12	Lymphoma (Lymphomas) 04/2024 - 10/2003
8	T-Cell Lymphoma (Lymphoma, T Cell) 09/2015 - 03/2002
6	Second Primary Neoplasms (Neoplasms, Second) 10/2019 - 01/2006
4	Body Weight (Weight, Body) 03/2022 - 03/2013
3	Adenocarcinoma of Lung 11/2022 - 05/2010
3	Adenocarcinoma 12/2017 - 05/2010
3	Colonic Neoplasms (Colon Cancer) 03/2015 - 01/2006
2	Adenoma (Adenomas) 04/2024 - 03/2013
2	Lung Neoplasms (Lung Cancer) 11/2022 - 01/2017
2	Radiation-Induced Neoplasms (Neoplasms, Radiation Induced) 01/2022 - 02/2013
2	Colitis 03/2015 - 01/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2008 - 01/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Necrosis 01/2019
1	Uterine Neoplasms (Uterine Cancer) 12/2017
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 06/2016
1	Obesity 01/2016
1	Colitis-Associated Neoplasms 03/2015
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2015
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2015
1	Radiation-Induced Leukemia (Leukemia, Radiation Induced) 11/2012
1	Leukemia 08/2012

Drug/Important Bio-Agent (IBA)

15	CarcinogensIBA 10/2022 - 06/2005
11	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 03/2002
10	Proteins (Proteins, Gene)FDA Link 03/2017 - 06/2005
8	CarbonIBA 11/2022 - 10/2003
6	IonsIBA 11/2022 - 10/2003
6	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 10/2017 - 05/2005
4	Hormones (Hormone)IBA 01/2021 - 07/2011
3	Estrogen ReceptorsIBA 10/2022 - 07/2011
3	LeptinIBA 03/2022 - 01/2016
3	CytokinesIBA 01/2019 - 01/2004
3	Drinking WaterIBA 10/2017 - 01/2006
3	Interleukin-9 Receptors (Interleukin 9 Receptor)IBA 08/2012 - 01/2004
2	A-Form DNA (A-DNA)IBA 10/2022 - 01/2013
2	Insulin (Novolin)FDA Link 03/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2013
2	Phenobarbital (Luminal)FDA Link 01/2021 - 03/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 08/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 07/2011
2	UraniumIBA 12/2015 - 07/2013
2	uranyl acetateIBA 12/2015 - 07/2013
2	Dextrans (Dextran)FDA Link 03/2015 - 01/2006
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2015 - 01/2006
2	Dihydrotachysterol (AT 10)IBA 03/2015 - 01/2006
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 04/2014 - 11/2011
2	Protein Isoforms (Isoforms)IBA 11/2011 - 03/2002
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2011 - 04/2006
2	beta CateninIBA 02/2006 - 01/2006
2	Codon (Codons)IBA 06/2005 - 03/2002
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 04/2024
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	CholesterolIBA 03/2022
1	PlasticsIBA 01/2019
1	Polycomb Repressive Complex 2IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2018
1	ENNGIBA 12/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	Losartan (Cozaar)FDA LinkGeneric 01/2016
1	ReninIBA 01/2016
1	Angiotensin IIIBA 01/2016
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	candesartanIBA 01/2016
1	AngiotensinsIBA 01/2016
1	CateninsIBA 03/2015
1	MutL Protein Homolog 1IBA 03/2015
1	Small Interfering RNA (siRNA)IBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	AminesIBA 03/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2013
1	Surface-Active Agents (Surfactants)IBA 03/2013
1	Apoprotein(a) (Apolipoprotein (a))IBA 03/2013
1	diisopropanolnitrosamineIBA 03/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	ApoferritinsIBA 11/2012
1	Interleukin-9 (Interleukin 9)IBA 08/2012
1	NucleolinIBA 08/2012
1	Sirolimus (Rapamycin)FDA Link 11/2011
1	Therapeutic UsesIBA 11/2011
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2011
1	TOR Serine-Threonine KinasesIBA 11/2011
1	benzocycloheptapyridineIBA 11/2011
1	LigandsIBA 07/2011
1	ErbB Receptors (EGF Receptor)IBA 07/2011

Therapy/Procedure

12	Radiotherapy 03/2022 - 01/2006
5	Therapeutics 11/2022 - 07/2009
2	Aftercare (After-Treatment) 01/2021 - 03/2013
2	Heavy Ion Radiotherapy 01/2015 - 01/2010
1	Intraperitoneal Injections 10/2022
1	Nuclear Power Plants 01/2021
1	Caloric Restriction 06/2016